[1] MARTINS-TEIXEIRA MB, CARVALHO I.Antitumour anthracyclines: progress and perspectives[J]. Chem Med Chem, 2020, 15(11): 933-948. [2] WANG YY, LIU T.Research advances in anthracyclines-related arrhythmias[J]. Journal of Practical Electrocardiology(实用心电学杂志), 2022, 31(4): 238-242. [3] National Pharmacopoeia Committee.Pharmacopoeia of the People's Republic of China, Part 1, Traditional Chinese Medicine[M]. Beijing: China Medical Science Press(中国医药科技出版社), 2020:134. [4] SU X, LI XY, ZHANG YJ, et al.Cardioprotective effect of saffron total glycoside tablets in patients with breast cancer receiving anthracycline-based chemotherapy: study protocol for a multicentre, randomised, parallel, double-blind, placebo-controlled clinical trial[J]. Annals of Palliative Medicine, 2021, 10(7): 8283-8291. [5] TISDALE JE, CHUNG MK, CAMPBELL KB, et al.Drug-induced arrhythmias: a scientific statement from the American heart association[J]. Circulation, 2020, 142(15): e214-e233. [6] BENJANUWATTRA J, SIRI-ANGKUL N, CHATTIPAKORN SC, et al.Doxorubicin and its proarrhythmic effects: a comprehensive review of the evidence from experimental and clinical studies[J]. Pharmacological Research, 2020, 151: 104542. [7] WU XL, SHI WW, WU TR. Oncology-Cardiology (肿瘤心脏病学)[M]. Shenyang: Liaoning Science and Technology Publishing House, 2019. [8] COLOMBO N, CIVELLI M, CARDINALE D, et al.Long QT syndrome and torsade de pointes after anthracycline chemotherapy[J]. Ecancermedicalscience, 2009, 3: 147. [9] PORTA-SANCHEZ A, GILBERT C, SPEARS D, et al.Incidence, diagnosis, and management of qt prolongation induced by cancer therapies: a systematic review[J]. Journal of the American Heart Association, 2017, 6(12): e007724. [10] PUDIL R, HORACEK JM, HORACKOVA J, et al.Anthracycline therapy can induce very early increase in QT dispersion and QTc prolongation[J]. Leukemia Research, 2008, 32(6): 998-999. [11] ZAMORANO JL, LANCELLOTTI P, MUNOZ D, et al.2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)[J]. European Journal of Heart Failure, 2017, 19(1): 9-42. [12] WANG JL, MA AQ, WANG KC, et al.The effects of bisoprolol on transient outward potassium current in ventricular cardiomyocytes of heart failure rats[J]. Chinese Journal of Molecular Cardiology(中国分子心脏病学杂志), 2018, 18(1): 2372-2375. [13] WANG YQ, JIANG JP.Clinical observation of bisoprolol combined with digoxin in the treatment of chronic heart failure with atrial fibrillation[J]. Health Research(健康研究), 2022, 42(3): 350-352, 356. [14] GIACCIO M.Crocetin from saffron: an active component of an ancient spice[J]. Crit Rev Food Sci Nutr, 2004, 44(3): 155-172. [15] WANG JR, GU YW, XU ZX. Study on the effect and mechanism of crocetin acid on experimental atrial fibrillation in rats[J/OL]. Chinese Pharmaceutical Journal(中国药学杂志).(2023-03-15)[2023-03-22]. http://kns.cnki.net/kcms/detail/11.2162.r.20230313.1351.002.html. [16] LIU T.Regulatory effects of on ion channels in cardiomyocytes[D]. Shijiazhuang: Hebei Medical University, 2016. [17] CHENG QL, LI HL, ZHANG DY.Study on anti-arrhythmia effect of crocetin[J]. Medical Journal of Chinese People's Liberation Army(解放军医学杂志), 2010, 35(4): 395-397. [18] CHEN ZY.Clinical study on the prevention of cardiotoxicity of anthracyclinechemotherapy drugs in breast cancer by Crocin[D].Ji'nan: Shandong University of Traditional Chinese Medicine, 2022. [19] ZUMURETI ABULAITI.Clinical observation and study on the therapeuticeffect of compound Saffron oral liquid in Chronic Heart Failure[D]. Urumqi: Xinjiang Medical University, 2020. |